PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
1 clinical trials · Condition
◉ Watch PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
| Record | Firm | Date |
|---|---|---|
| Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) (NCT06635824) | Genmab | 2024-11-25 |
Track PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.